• The firm has launched a growth and consolidation project in the sector, integrating Centro Psicosanitario Galiani (Seville) and Orientak (Madrid) as the foundation of this nationwide platform.


• This investment is part of Miura’s Impact strategy and is designed to address mental health challenges through prevention and intervention, with clinical excellence and multi- and interdisciplinary care as core pillars.

Miura Partners has joined forces with the founders of the mental healthcare centres Centro Psicosanitario Galiani (Seville) and Orientak (Madrid), José Antonio Galiani and Eva Milla respectively, to launch a national growth and consolidation project in Spain’s mental health sector.

The aim is to create a leading group in mental healthcare and emotional wellbeing in Spain, combining acquisitions of established centres by region and specialisation with organic growth initiatives. These include expanding and opening new centres, attracting top talent, investing in technology, and strengthening therapeutic interventions with multi- and interdisciplinary approaches—incorporating lifestyle medicine as a key element of care.

The management team is led by Pedro Álvarez as CEO—who previously led Miura’s high-growth project Tiendanimal—and is dedicated to enhancing patient care through clinical and operational excellence. Claudio Priore, formerly Regional Director for Clariane in Andalusia and Extremadura, has also joined the project as COO.

Together, Centro Psicosanitario Galiani and Orientak currently serve more than 4,000 patients across their combined facility footprint of over 1,800m² in Seville and Madrid.

Spain has over 5,000 outpatient and day hospital mental healthcare centres. The sector has shown sustained historical growth that has accelerated in recent years due to social, technological, and economic factors. Rising social isolation, uncertainty about the future, growing difficulties in managing emotions, dependence on new technologies, and a challenging socio-economic environment have all contributed to the rising prevalence of mental health disorders—particularly among young people.

Impact Thesis: Contributing to Healthier Lives

This investment is aligned with Miura Partners’ Impact strategy, ensuring a responsible, innovative, and evidence-based approach to mental healthcare. The goal is to deliver integrated, holistic, and high-quality care that promotes self-care and prevention, reduces the stigma around mental health challenges, and ultimately contributes to healthier lives.

About Centro Psicosanitario Galiani and Orientak

Centro Psicosanitario Galiani, founded in 2016 in Seville by José Antonio Galiani, is the largest independent outpatient mental health centre in Andalusia. It offers services across 18 psychology specialties, integrating a range of medical and wellness disciplines such as psychiatry, nutrition, physiotherapy, neuropsychology, and speech therapy. The centre operates a hybrid care model, combining in-person and online services.

Founded in 2017 in Madrid by Eva María Milla Molina, Orientak is a specialist day hospital focused on mental health care for children and adolescents. It employs a bio-psychosocial model and operates across five key areas: genetics, psychological expertise, education, psychonutrition, and social support. Additionally, through its Vilem brand, Orientak extends its services to patients aged 18 and over, offering tailored outpatient and day hospital therapy adapted to each patient’s specific needs.

About Miura Partners

Miura Partners is a purpose-driven Private Equity firm. With offices in Barcelona and Madrid, the firm specializes in investing in small and medium-sized family-owned and entrepreneurial companies. Miura provides attractive growth and innovation plans with a clear focus on sustainability and internationalization.

Since inception in 2008, Miura has raised five primary funds across its Buyout and Impact strategies, alongside two continuation vehicles in the Agribusiness and Dental Health verticals. The firm currently manages assets exceeding €1.5bn and has completed more than 90 investments worth in excess of €4bn.